MORGAN STANLEY - DIFFUSION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$7,000
-12.5%
27,400
-0.0%
0.00%
Q4 2021$8,000
+100.0%
27,408
+270.2%
0.00%
Q3 2021$4,000
-20.0%
7,403
+0.0%
0.00%
Q2 2021$5,000
-44.4%
7,400
-26.0%
0.00%
Q1 2021$9,000
+800.0%
10,000
+900.0%
0.00%
Q4 2020$1,0001,000
+2602.7%
0.00%
Q1 2020$0370.0%0.00%
Q4 2019$0
-100.0%
37
-96.3%
0.00%
Q3 2019$2,000
+100.0%
1,000
+298.4%
0.00%
Q2 2019$1,0002510.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 89,848$66,0000.75%
Virtu Financial LLC 285,621$209,0000.02%
GSA CAPITAL PARTNERS LLP 30,180$22,0000.00%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 43,868$32,0000.00%
Hoover Financial Advisors, Inc. 4,225$3,0000.00%
Renaissance Technologies 1,375,579$1,004,0000.00%
Frontier Wealth Management LLC 25,000$18,0000.00%
UBS Group AG 36,910$27,0000.00%
IFP Advisors, Inc 0$00.00%
OSAIC HOLDINGS, INC. 29,569$22,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders